P/E ratio for LivaNova (LIVN)
P/E ratio as of April 2024 (TTM): > 1000
According to LivaNova's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 1110.4. At the end of 2022 the company had a P/E ratio of -34.5.
P/E ratio history for LivaNova from 2015 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -34.5 | 7.32% |
| 2021 | -32.1 | 243.72% |
| 2020 | -9.35 | -60.2% |
| 2019 | -23.5 | 0.45% |
| 2018 | -23.4 | -84.78% |
| 2017 | -154 | 340.88% |
| 2016 | -34.9 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Merit Medical MMSI | 42.3 | -96.19% | 🇺🇸 USA |
 Inari Medical
NARI | -769 | -169.22% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.